Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   

incontinence10 - shaft1 - cardiac complications1 - kidney fluid filtration1 - standard kidney biopsy1 - kidney masses1 - screening test1 - markers of prostate cancer1 - plos1 - sexually transmitted diseases2 - surface enhanced raman spectroscopy1 - artificial1 - sex after prostate surgery1 - calcium-rich foods1 - indinavir1 - pkd2 - pluripotent stem cells1 - leak-point pressure4 - nephrin1 - lithium1 - gonococcal infection2 - seminal vesicle stones1 - matrix component3 - ketamine1 - absorptive hypercalciurics1 - specialized high-fat1 - blood pressure4 - genital tracts1 - srs1 - aminoaciduria1 -